AJP - Heart ADInstruments data acquisition for life science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 270: H1149-H1158, 1996;
0363-6135/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Descamps, L.
Right arrow Articles by Cecchelli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Descamps, L.
Right arrow Articles by Cecchelli, R.

AJP - Heart and Circulatory Physiology, Vol 270, Issue 4 1149-H1158, Copyright © 1996 by American Physiological Society

ARTICLES

Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells

L. Descamps, M. P. Dehouck, G. Torpier and R. Cecchelli
Institut National de la Sante et de la Recherche Medicale U325-Service d'Etude et de Recherche sur les Lipoproteines et l'Atherosclerose, Institut Pasteur, Lille, France.

A cell culture model of the blood-brain barrier consisting of a coculture of bovine brain capillary endothelial cells (BBCECs) and astrocytes has been used to examine the mechanism of iron transport to the brain. Binding experiments showed that BBCECs express 35,000 high-affinity (concn at 50% receptor saturation = 11.3 +/- 2.1 nM) transferin (Tf) receptors per cell. In contrast to apo-transferrin (apoTf) we observed a specific transport of holo-transferrin (holoTf) across BBCECs. This transport was inhibited completely at low temperature. Moreover, the anti-Tf receptor antibody (OX-26) competitively inhibited holoTf uptake by BBCECs. Pulse-chase experiments demonstrated that only 10% of Tf was recycled to the luminal side of the cells, whereas the majority of Tf was transcytosed to the abluminal side; double-labeling experiments clearly demonstrated that iron crosses BBCECs bound to Tf. No intraendothelial degradation of Tf was observed, suggesting that the intraendothelial pathway through BBCECs bypasses the lysosomal compartment. These results clearly show that the iron-Tf complex is transcytosed across brain capillary endothelial cells by a receptor-mediated pathway without any degradation.


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
P. L. TUMA and A. L. HUBBARD
Transcytosis: Crossing Cellular Barriers
Physiol Rev, July 1, 2003; 83(3): 871 - 932.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. J. Lee, B. Engelhardt, J. Lesley, U. Bickel, and W. M. Pardridge
Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in Mouse
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1048 - 1052.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Fenart, A. Casanova, B. Dehouck, C. Duhem, S. Slupek, R. Cecchelli, and D. Betbeder
Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain Barrier
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1017 - 1022.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
D. Wu and W. M. Pardridge
Pharmacokinetics and Blood-Brain Barrier Transport of an Anti-Transferrin Receptor Monoclonal Antibody (OX26) in Rats after Chronic Treatment with the Antibody
Drug Metab. Dispos., September 1, 1998; 26(9): 937 - 939.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online